Date: 2016-11-28
Type of information: Nomination
Compound:
Company: OSE Immunotherapeutics (France)
Therapeutic area: Cancer - Oncology - Autoimmune diseases
Type agreement: nomination
Action mechanism:
Disease:
Details: * On November 28, 2016, OSE Immunotherapeutics announced the appointment of Dr. Frédérique Corallo to the position of Chief Medical Officer, Immunology, further strengthening the Company’s scientific and medical expertise within this therapeutic area. Dr. Corallo will lead the development of OSE Immunotherapeutics’s innovative products, with a particular emphasis on autoimmune diseases.
Dr. Corallo is a physician, specializing in immunology, and has over 25 years of global experience in the pharmaceutical and biotechnology industries. Prior to joining OSE Immunotherapeutics, she spent
over 10 years as Medical Director at Biogen. Dr. Corallo previously held management positions in Medical Affairs and Clinical Research at multiple biopharmaceutical companies, including Janssen Cilag and Sanofi (Hoechst Marion Roussel). Throughout her career, she has led strategic and operational management of immunology-related clinical development programs and medical marketing activities.
Financial terms:
Latest news:
